Abstract Exposure of rat aortlc vascular smooth muscle cells to cr-thrombm resulted m the appearance of szs-mnducmg factor-A (SWA)-hke DNA binding activity This response to cy-thrombm was delayed (detectable at 1 hour) compared with the rapid actlvatlon (15 to 30 mmutes) by platelet-denved growth factor and the cytokme mterleukm-6 cw-Thrombm-induced SIF-A was sensitive to treatment with the tyrosme kmase mhlbltor gemstem The tbrombm mhlbltor hnudm prevented the a-thrombm-mediated SIF-A mductlon Cyclohexlmlde had no effect on the ability of cu-thrombm to Induce SIF-A, suggesting that mductlon does not require new protein synthesis a+Tbrombm-induced SIF-A could be resolved into two addltlonal subcomplexes termed SIF-AF and SIFAs Antibodies against Stat3 reacted with a-thrombmn-induced SIF-A,, suggesting that Stat3 or a related protein 1s present m this subcomplex Induction of SIF-A DNA bmdmg actlvlty may contribute to cz-thrombm-mechated cellular responses, including wound healing, cell prohferatlon, and mflammatlon m the vasculature (Hypertension. 1997;29[part 2]:356360.) Key Words l thrombm l transcription factors l muscle, smooth, vascular l signal transduction T he multifunctional serme protease a-thrombm, generated at sites of vascular injury, has central functions in hemostasis but also promotes a wide range of cellular responses (reviewed in References 1 and 2) In ad&tion to its potent sttmulatory effect on platelet aggregatlon,3 it acts as a rmtogen m lymphocytes4 and aotic VSM cellsJ.6 and stimulates the induction of the growthassociated proto-oncogene C--OS 7.8 Acting through a seventransmembrane, G protem-coupled receptor, a-thrombm activates phosphohpase C and subsequent generation of mosit01 trisphosphate, which results in an increase m mtracellular Ca2+ 991" It also activates a series of protein kmase cascades, mcludmg protein kinase C, p42/p44 rmtogen-achvated protein (MAP) kinases, ~38 MAP kmase, Src farmly kmases, and Janus kinases (JAK).6,1'-1S Shmulatlon of these signal transduction pathways may collectively contribute to the ability of a-thrombm to cause multiple blologlcal responses
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In recent reports, we and others demonstrated that Ang II, coupling through the G protein-coupled angiotensm type 1 (AT,) receptor, stimulated the STAT pathway.16.18 Six STAT family members (Stat1 through Stat6) have been identified, with adchtlonal subtypes 19 Upon tyrosme phosphorylatlon, STAT proteins form homodlmers or heterochmers and translocate to the nucleus 1920 Binding of STAT proteins (Stat1 and Stat3) to the regulatory DNA element SIE can result m the formation of DNA-protein complexes referred to as SIF 19 For example, the c-fos gene promoter contains an SIE DNA responsive to the STAT pathway. 19 Depending on the hgand, SIF appears m three different forms* complex A, B, and C (SIF-A, SIF-B, and SIF-C) SIF-A contains Stat3-Stat3 homodimer, SIF-B contains Statl-Stat3 heterodlmer, and SIF-C contains Statl-Stat1
From the Wels Center for Research, Gelsinger Chmc, Danvllle, Pa Correspondence to G Jayarama Bhat, PhD, Wels Center for Research, 100 N Academy Ave. Danvdle, PA 17822 0 1997 American Heart Assoclatlon, Inc homodlmer. 19 PDGF induces all the three complexes; IL-6 induces mamly complex A, and interferon gamma mainly complex C *l,** In the present study, we determined whether a+thrombm was capable of stimulating the STAT pathway m rat aortlc VSM cells. Using electrophoretic moblllty shift assays, which measure the bmdmg of activated STAT proteins to [32P]-labeled SIE DNA in vitro,16,17 we showed that a-thrombm stlmulated the formation of DNA-protein complex SIF-A. The characteristics of a-thrombm-induced SIF-A formation observed m the present study were similar to the stimulation of SIF-A by Ang II m rat cardiac fibroblasts and Chinese hamster ovary Kl (CHO-Kl) cells expressmg AT, receptors 161'7
Materials

Methods
Cell culture media, fetal bovine serum, antibiotics, tissue culture flasks, and murme recombinant IL-6 were purchased from Life Technologies ol-Thrombm and r-hnuchn were purchased from Sigma Chemical Co [y-32P]ATP was purchased from DuPont-NEN, polyclonal antibodies to Statl, Stat2, Stat3, and Stat4 were purchased from Santa Cruz Biotechnology, PDGF was purchased from Upstate Biotechnology Cell Culture and Treatment With Agonists VSM cells were isolated from the thoracic aorta of rats (150 to 180 g) by enzymatic dissociation as previously described 23 VSM cells were grown m mechum (50% Dulbecco's modified Eagle's medium and 50% F-12) containing 10% heat-inactivated fetal bovine serum, 2 mmofi L-glutamate, 100 U/mL pemc&n, and 100 pg/mL streptomycm Cells between passages 5 and 10 were seeded for 24 hours, serum-starved for 24 to 48 hours, and stimulated with agonists as indicated
Preparation of Nuclear Extracts
Nuclear extracts were prepared as previously described '617 After n-thrombm or other treatments, VSM cells were rinsed with phosphate-buffered saline at 0°C and scraped mto the same buffer Harvested cells were resuspended m 10 vol hypotomc buffer (10 mmol/L HEPES [pH 7 91, 10 mmol/L KCl, 15 mmol/L Selected Abbreviations and Acronyms Ang II = angiotensin II IL-6 = interleukin-6 PDGF = platelet-derived growth factor SIE = sis-inducing element SIF-A = s&inducing factor A STAT = signal transducers and activators of transcription VSM = vascular smooth muscle MgC12, 0.5 mmol/L dithiothreitol), supplemented with protease and phosphatase inhibitors, incubated for 10 minutes on ice, and sedimented. Cells were resuspended with 0.6 mL of the same buffer, dounce-homogenized, and sedimented at 1OOOg for 10 minutes, and the pellet (nuclei) was collected. The pelleted nuclei were incubated for 30 minutes at 4°C in high salt buffer (20 mmol/L HEPES [pH 7.91, 25% glycerol, 400 mmol/L NaCl, 1 mmol/L EDTA) supplemented with protease and phosphatase inhibitors and sedimented at 12 000 rpm in a microcentrifuge for 15 minutes at 4°C. This supernatant (nuclear extract) was dialyzed against low salt buffer (same as the high salt buffer except that NaCl was 50 mmol/L,) for 4 hours, protein concentration was determined, and the extract was stored at 80°C.
Electrophoretic Mobility Shift Assay
Mobility shift assays were performed as previously described.16.17 Five micrograms of nuclear extract was incubated with 1 pg poly(dI-dC) in 20 PL of 10 mmol/L HEPES (pH 7.9), 50 mmol/L NaCl, 1 mmol/L EDTA, and 10% glycerol for 20 minutes at 25°C. The samples were incubated with 1 or 2 fmol radiolabeled probes (approximately 5000 cpm) for 10 minutes at 25°C. The sequence of the probes used in the present study has been previously described.16 Binding reactions were resolved on a 4% native polyacrylamide gel containing 0.5X Tris borate-EDTA buffer (25 mmol/L Tris, 25 mmol/L boric acid, 0.5 mmol/L EDTA). Gels were run at 200 V for 2 or 5 hours in a cold room (4°C to S'C) and exposed to x-ray film.
Results
Effect of cu-Thrombin on Induction of SIF Activity
For determination of whether a-thrombin was capable of inducing SIF activity, rat aortic VSM cells were treated with cy-thrombin for differing periods of time, and nuclear extracts were prepared and subjected to electrophoretie mobility shift assays (2 hours, 200 V) using r3*P]-a-Thrombin E .g
Interleukin-6
Bhat et al SIF Activation by cY-Thrombin onstrates the formation of nuclear SIF complex induced by a-thrombin, IL-6, and PDGF. IL-6-and PDGF-induced activation was rapid and maximal at 15 to 30 minutes. In contrast, induction of SIF by a-thrombin was delayed, with initial activity being detected at 1 hour and a maximal response at 3 to 6 hours. The positive control PDGF induced three different SIF complexes (complexes A, B, and C), and IL-6 induced mainly one (complex A), in agreement with published reports.l6,*Q* When cr-thrombin-, IL-6-, and PDGF-induced samples were run on the same gel, the cu-thrombin-induced SIF comigrated with IL-6-induced SIF-A (data not shown). When the gels were run for longer periods of time (5 hours at 200 V), the a+thrombin-induced SIF complex could be further resolved into two distinct subcomplexes (see Fig 3) . These results indicate that a-thrombin and PDGF/IL-6 exhibit distinct kinetics of SIF formation. The delayed appearance of SIF by c-u-thrombin is similar to the time course of SIF induction by Ang 11,16J7 indicating that a common mechanism may govern the activation of SIF by a-thrombin and Ang II.
Characterization of cu-Thrombin-Induced SIF Response
To determine whether the a-thrombin-induced SIF is mediated through an cY-thrombin-specific receptor, we pretreated the cells with hirudin for 15 minutes and subsequently exposed them to cy-thrombin for 1 hour. Hirudin acts as a specific inhibitor of a-thrombin actions and has been used to block thrombin-mediated proliferation of smooth muscle cells.5 Nuclear extracts were prepared and subjected to electrophoretic mobility shift assay. As shown in Fig 2A, lane 3 , pretreatment of cells with hirudin completely inhibited a-thrombin-induced SIF formation. To determine whether the SIF response by cw-thrombin required the action of tyrosine kinases, we pretreated the cells with the tyrosine kinase inhibitor genistein before the addition of cu-thrombin. As shown in Fig 2A, genistein prevented cY-thrombin-induced formation of SIF (lane 4). These data indicate that the a-thrombin-induced signaling pathway involves the action of tyrosine kinases. We also PDGF s cu observed that induction of SIF by a-thrombin was insensitive to cycloheximide treatment, suggesting that the induction is a posttranslational event (data not shown). SIF induction by cu-thrombin was detected at concentrations of a-thrombin as low as 0.3 nmol/L (Fig 2B) .
a-Thrombin-Induced SIF Complex Contains Stat3 or a Related STAT Protein PDGF-or IL-6-induced SIF-A has been shown to contain Stat3 protein. 17~22 Since the cu-thrombin-induced SIF complex comigrated with PDGF-or IL-6-induced complex A, we determined whether the cu-thrombin-induced SIF contained Stat3 as a component protein. Nuclear extracts prepared from cu-thrombin-stimulated cells were incubated with anti-Stat3, and the resulting DNA-protein complexes were analyzed in a gel mobility shift assay. As shown in Fig 3A, the cw-thrombin-induced SIF could be resolved into two distinct complexes. We refer to the slower migrating complex as SIF-As and the faster migrating complex as SIF-AF. Addition of anti-Stat3 supershifted mainly SIF-AF, indicating that Stat3 or a related protein is a component of a-thrombin-induced SIF-A, (lane 3). Addition of unlabeled SIE-DNA (loo-fold excess) competed away the cu-thrombin-induced SIF and supershifted complexes (lane 4). These results suggested that cY-thrombin induced specific SIF complexes. Addition of anti-Statl, anti-Stat2, and anti-Stat4 did not supershift the cu-thrombin-induced SIF-A (Fig 3B, lanes 3, 4, 
Discussion
Using the c-&s regulatory element SIE, we demonstrated m the present study that cr-thrombm stimulates the formation of SIF-A complex m rat aortlc smooth muscle cells. We also demonstrated that the cu-thrombm-induced SIF-A complex can be further resolved mto a faster and slower migrating SIF, termed SIF-AF and SIF-As, respectlvely Stat3 or a related protein was present m SIF-AF, however, the identity of the STAT member m SIF-As is not known As shown earlier for cytokmes,*4 treatment of cells with genistem inhibited the a-thrombm-Induced SIF-A, suggesting that tyrosme kmases were Involved m the slgnal transduction pathway leading to the DNA bmdmg activity Cyclohexlmlde treatment did not affect the ability of cy-thrombm to stimulate the SIF-A, mdlcatmg that the mductlon did not require new protein synthesis. We also demonstrate evidence that IL-6 Induces SIF-A activity m VSM cells.
With respect to the time course, cw-thrombm-Induced SIF-A slgmficantly differed from that elicited by PDGF or IL-6 In contrast to the rapid mductlon of SIF by PDGF and IL-6 (maximal within 30 minutes), a-thrombm mduced a delayed formation of SIF, with mltlal activity detectable at 1 hour and maxlmal at 3 to 6 hours This delay by cu-thrombm appears similar to the Ang II-induced delayed activation of SIF-A observed previously m cardiac fibroblasts,l6 CHO-Kl cells expressing AT,* receptors,'7 and CHO-Kl cells expressmg endothelm receptors 25 These data suggest that SIF-A activation by all three dlfferent agonists (Ang II, endothelin, and a-thrombm) may involve a common mechanism
In cultured VSM and endothehal cells, a-thrombm was shown to induce c-fos mRNA m a transient fashion, with mductlon detected at 15 to 30 mmutes but maximal at 60 mmutes after exposure 78 The 5' promoter region of the c-j& gene contains three mam regulatory elements (1) the SIE, controlled by the STAT pathway; (2) the serum-response element, which 1s activated by the MAP kmase pathway, and (3) the cAMP/Ca"-response element, which IS responsive to protein kmase A 2627 Since cY-thrombm 1s a potent inducer of the MAP kmase cascade (within 5 mmutes)6 and increases intracellular Ca*+,78 it IS likely that these two pathways contribute to the early phase m the mductlon of c-j&s mRNA Since SIF-A mductlon by cu-thrombm 1s delayed (1 hour), the STAT pathway may contrlbute to c-fos mductlon at 1 hour It 1s not known at present whether JAK kmases are mvolved m cy-thrombm-stimulated tyrosme phosphorylatlon of Stat3 The reports of activation of JAK kmases by cr-thrombm m human platelets'5 suggest a role for these kmases m Stat3 tyrosme phosphorylatlon It is notable that the human ol-thrombm receptor sequence contams a potentlal Stat3 bmdmg site, YXXQ (ammo acid YPMQ; (206) (207) (208) (209) ,9 which 1s demonstrated to be important for the mteractlon of Stat3 with cytokme receptors ** Whether Stat3 binds to the YPMQ motif in the a-thrombm receptor requu-es further study It 1s also important to pomt out that the a-thrombm-, PDGF-, and IL-6-mduced SIF responses were variable between cultures This probably reflects, at least m part, differences m the level of receptors expressed m these pnmary cultures Although studies m primary cultures are Important for estabhshmg the physlologlcal relevance of thrombm-induced SIF activation, future studies on the mechanism of SIF mductlon (activation of JAK kmases and Stat3 tyrosme phosphorylatlon) may be better addressed in model cell lines transfected with a-thrombm receptors.
We show in this study that Stat3 1s a component of a-thrombm-induced SIF-AF. Stat3 was originally ldentlfied as an IL-6-dependent transcnptlon factor that bound to the acute phase response element m a variety of promoters of genes encoding acute phase response protems. 
